JANX Competitors & Alternatives
Compare Janux Therapeutics Inc with similar stocks in the same industry
Biotechnology
JANX
Main Stock$13.67
Tradestie Score
56
Market Cap
$1.42B
Revenue Growth
21.8%
Analyst Upside
+196.8%
Top Competitors
217 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
SEPN
Septerna, Inc. Common Stock
|
$36.26
|
$847.12M | - | 60 | Compare |
|
XNCR
Xencor, Inc.
|
$12.38
|
$843.75M | - | 53 | Compare |
|
GHRS
GH Research PLC Ordinary Shares
|
$21.33
|
$841.74M | - | 55 | Compare |
|
KOD
Kodiak Sciences Inc Common Stock
|
$34.13
|
$832.47M | - | 49 | Compare |
|
URGN
UroGen Pharma Ltd. Ordinary Shares
|
$29.98
|
$824.20M | - | 62 | Compare |
|
IVA
Inventiva S.A. American Depository Shares
|
$3.89
|
$821.84M | - | 53 | Compare |
|
MBX
MBX Biosciences, Inc. Common Stock
|
$35.03
|
$800.41M | - | 57 | Compare |
|
IOVA
Iovance Biotherapeutics, Inc. Common Stock
|
$4.03
|
$799.70M | - | 53 | Compare |
|
KURA
Kura Oncology, Inc.
|
$8.95
|
$798.53M | - | 56 | Compare |
|
VIR
Vir Biotechnology, Inc. Common Stock
|
$8.69
|
$791.82M | - | 47 | Compare |
More JANX Analysis
Data updated: Jun 12, 2026 | Industry: Biotechnology (SIC 2834)
217 stocks in this industry